Tag Archives: Defective Drug Lawsuit

Featured Stories

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

The family of a Texas woman who died just months before her 60th wedding anniversary believes she would be alive today were it not for Pradaxa (dabigatran). According to a report from the Houston Press, Pradaxa patient Loraine Franklin fell and hit her head last December, resulting in an intracranial ...

Read More

Crash on N.State Pkwy Kills Port Jefferson Station Man

Single-Car Crash on Northern State Parkway Kills Port Jefferson Station Man

A Port Jefferson Station man was killed on Wednesday due to a single-vehicle crash on the Northern State Parkway in Dix Hills. Police are investigating the accident, Newsday reports. According to Newsday, the 81-year-old man was driving a Nissan Altima west in the right lane, west of Exit 42. He ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Proton Pump Inhibitors May Lower Magnesium Levels, FDA Warns

< "http://www.yourlawyer.com/topics/overview/Proton_pump_inhibitors">Proton pump inhibitors can lower magnesium levels if the popular heartburn drugs are used over a long period of time, the U.S. Food & Drug Administration (FDA) has warned. Low serum magnesium levels (hypomagnesemia) can result in serious health … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , , , |

Users of Plavix, Valium, Other Meds Could Suffer Reactions if they Carry CYP2C19 Gene Variant

Does a gene variant explain a U.S. lawmaker’s odd behavior? According to Rep. David Wu, an Oregon Democrat, a variant in the CYP2C19 gene, which plays a role in metabolizing some drugs, like < "http://www.yourlawyer.com/topics/overview/Plavix-Cerebral-Gastrointestinal-Bleeding-Hemorrhaging-Lawsuit-Lawyer">Plavix and Valium was the reason … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

Stevens-Johnson Syndrome Follows Teen’s Use of Eye Drops

A 19-year-old girl in the United Kingdom required weeks of intensive care treatment and is looking at months of follow-up treatment following a dangerous drug reaction called < "http://www.yourlawyer.com/topics/overview/stevens_johnson_syndrome">Stevens-Johnson syndrome after using Optrex eye drops. According to the Voice Online, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

Abacavir Safety Review Shows No Heart Attack Link, Conflicts with Some Earlier Studies

U.S. health regulators said today said that a safety review did not find a connection between < "http://www.yourlawyer.com/practice_areas/defective_drugs">abacavir and an increased risk of heat attacks. Abacavir—sold under brand names Ziagen, Trizivir, and Epzicom – is used in the treatment of … Continue reading

Posted in Pharmaceuticals | Tagged , , , |

Multaq Patients Should Undergo Liver Function Tests

European regulators recently warned that < "http://www.yourlawyer.com/topics/overview/multaq-dronedarone-liver-damage-failure-lawsuit-lawyer-attorney">Multaq (donedarone) could put patients at risk for severe liver injuries. The European Medicines Agency (EMA) is now recommending that doctors perform liver function tests before treating atrial fibrillation patients with Multaq. The European … Continue reading

Posted in Multaq, Pharmaceuticals | Tagged , , , , |

Avastin Breast Cancer Decision Will Be Appealed in June

The maker of < "http://www.yourlawyer.com/topics/overview/Avastin-Side-Effects-Lawyers-Lawsuit-Attorney">Avastin will attempt this summer to convince the U.S. Food & Drug Administration (FDA) that it made a mistake when it decided to revoke the pricey drug’s approval as a treatment for advanced breast cancer. Roche’s … Continue reading

Posted in Legal News | Tagged , , , , , |

Extenze Tablets Recalled for Undeclared Ingredient

Biotab Nutraceuticals, Inc. is conducting a voluntary recall of two lots of < "http://www.yourlawyer.com/practice_areas/defective_drugs">Extenze Nutritional Supplement Tablets, the U.S. Food and Drug Administration (FDA) just announced. Some packages bearing lot numbers 0709241 and 0509075 are counterfeit products containing undeclared drug … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

Acetaminophen, Ibuprofen Should be taken with Caution

< "http://www.yourlawyer.com/topics/overview/Acetaminophen-Liver-Damage-Injury-Failure-Lawsuit-Lawyer">Acetaminophen and ibuprofen, painkillers found in just about everyone’s medicine cabinet, can cause some serious side effects. Acetaminophen, the active ingredient Tylenol and other over-the-counter drugs, as well as some prescription painkillers, can cause serious liver damage if too … Continue reading

Posted in Acetaminophen / Tylenol | Tagged , , , , |

Osteoporosis Drugs Linked to Thigh Fractures, Yet Again

Bone loss drugs in the class of < "http://www.yourlawyer.com/topics/overview/Bisphosphonates">bisphosphonates have, again, been linked to bone fractures of the femur (thigh bone). Web MD said that a recent, large review of over 200,000 post-menopausal women found that those taking bisphosphonates—drugs sold … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged , , , , , |

Antipsychotic Drugs Pose Risks to Newborns, FDA Says

U.S. health regulators have ordered that cautions be added to the labels of ALL antipsychotic drugs regarding their risk of abnormal muscle movements (extrapyramidal symptoms or EPS) and withdrawal syndromes in newborns when used in pregnancy. The new cautions will … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.